Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
28 studies found for:    " December 12, 2007":" January 11, 2008"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
RSS Create an RSS feed from your search for:
" December 12, 2007":" January 11, 2008"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed Relationship Between HIV-1 Subtype and ARV Response
Condition: HIV Infections
Intervention: Drug: NRTI/NNRTI/ Kaletra
2 Completed Safety of and Immune Response to Two HIV Vaccines: SAAVI DNA-C2 Boosted With SAAVIMVA-C, in HIV-Negative Adults
Condition: HIV Infections
Interventions: Biological: SAAVI DNA-C2 vaccine;   Biological: SAAVI MVA-C vaccine;   Biological: Placebo
3 Completed Family Access to Care Study (FACS)
Condition: HIV Infections
Intervention:
4 Completed Adherence and Acceptability to and Blood Levels of Tenofovir Gel and Tablets in HIV Uninfected Women
Condition: HIV Infections
Interventions: Drug: Tenofovir disoproxil fumarate;   Drug: Tenofovir gel
5 Completed
Has Results
HIV Non Occupational Post-Exposure Prophylaxis (PEP)
Condition: HIV Infections
Intervention: Drug: TRUVADA + raltegravir
6 Completed HIV Resistance and Treatment Strategies
Condition: HIV Infections
Intervention:
7 Completed Interventional Study of Mucosal and Antimicrobial Responses to Repeated Vaginal Applications of Tenofovir Gel in HIV Uninfected Women
Condition: HIV Infections
Interventions: Drug: Tenofovir gel;   Drug: Tenofovir gel placebo
8 Completed Evaluation of 4 New Simplified Antiretroviral Treatments in Naive HIV-1 Infected Patients in Africa (ANRS 12115 DAYANA)
Condition: HIV Infections
Interventions: Drug: Tenofovir/Emtricitabine (Truvada) and Nevirapine;   Drug: Tenofovir/Emtricitabine/Efavirenz (Atripla);   Drug: Tenofovir (Viread) and Lopinavir/Ritonavir (Aluvia);   Drug: Tenofovir/Emtricitabine (Truvada) and Zidovudine
9 Completed CNS (Central Nervous System) Viral Dynamics and Cellular Immunity During AIDS
Condition: HIV Infections
Intervention:
10 Completed Understanding the Increased Risk of Cardiovascular Disease in People With HIV
Condition: HIV Infections
Intervention: Drug: Antiretroviral Therapy (ART)
11 Completed Role of Positive Affect in Adjustment to HIV
Condition: HIV Infections
Intervention:
12 Completed Family-Based HIV Prevention for Latinos
Condition: HIV Infections
Interventions: Behavioral: Family-Based HIV Prevention for Latinos;   Behavioral: General Health Promotion
13 Unknown  Energy Specific Far Infrared Radiation Treatment for AIDS
Condition: HIV Infections
Intervention: Radiation: Far infrared
14 Completed Peer-Driven Intervention to Enroll Minorities/Women in HIV/AIDS Clinical Trials (the ACT2 Project)
Condition: HIV Infections
Interventions: Behavioral: Peer-driven intervention;   Behavioral: Time-matched health education
15 Completed Pharmacokinetics of the Tablet Formulation of Lopinavir/r as Standard and Increased Dosage During Pregnancy
Conditions: HIV Infections;   Pregnancy
Interventions: Drug: Lopinavir / ritonavir;   Drug: Lopinavir/ritonavir
16 Completed Evaluation of Opt-Out Rapid HIV Testing in the Emergency Department
Condition: HIV Infections
Intervention: Other: Non-targeted opt-out rapid HIV screening
17 Unknown  Stress-Reducing Interventions in HIV+ Patients: Pilot
Conditions: Stress Disorders, Post-Traumatic;   HIV Infections
Intervention: Behavioral: Prolonged Exposure Therapy
18 Completed Effectiveness of Enhanced Counseling and Observed Therapy on Antiretroviral Adherence in People With HIV
Conditions: HIV Infections;   Acquired Immunodeficiency Syndrome
Interventions: Behavioral: Motivational interviewing with cognitive behavioral therapy;   Behavioral: Modified directly observed therapy
19 Completed Antiretrovirals and Rate of Progression in Carotid Artery Intima-medial Thickness in HIV
Conditions: HIV Infections;   Atherosclerosis
Intervention:
20 Completed HIV-HCV Coinfection: Impact of Immune Dysfunction
Conditions: HIV Infections;   Hepatitis
Intervention:

   Previous Page Studies Shown (1-20) Next Page (21-28) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.